GLP+ supplies research-grade Semaglutide across Indonesia. The original GLP-1 weight management peptide, available in 10mg vial or pre-filled injector pen. Nationwide delivery, IDR pricing, WhatsApp ordering.
One lab-verified compound, two formats. All prices in IDR, no hidden fees.
The longest-studied GLP-1 receptor agonist in the weight management category.
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist originally developed for type-2 diabetes research and later studied extensively for weight management. It works by mimicking the body's natural GLP-1 hormone, which is involved in appetite regulation, gastric emptying, and insulin response.
In published research, Semaglutide has the longest track record of the three weight management GLPs we carry. It is the parent molecule behind the brand-name products that brought GLP-1 weight research into the mainstream. Because of its long half-life, Semaglutide is typically dosed once weekly in published protocols.
We supply Semaglutide in two formats. The 10mg vial is the standard research format, requires reconstitution with bacteriostatic water (which we can include with your order), and offers full dosing flexibility. The 10mg pre-filled pen is the same lab-verified peptide loaded into a click-to-dose injector, ready to use straight from the box. Both are tested independently at 99%+ purity.
GLP+ is operated by Peptide+, Indonesia's most-reviewed peptide source with a 5.0-star Google rating from 60 verified customers at our Canggu flagship. Pricing is in Indonesian Rupiah with no hidden fees. Our WhatsApp team responds within minutes during business hours and dispatches nationwide.
The science, translated for non-researchers.
Semaglutide is a synthetic peptide that mimics one gut hormone called GLP-1. It is the original GLP family weight management peptide and the longest-studied of the three we carry. Its single-receptor mechanism produces meaningful weight reduction plus a growing body of evidence for downstream cardiovascular benefits.
Slows how fast food leaves your stomach and signals fullness to your brain. You feel full sooner after a meal and stay full longer.
In practice: smaller portions feel normal, snacking urges fade, food noise quietens down between meals.
Improves how your body releases insulin after meals, helping keep blood sugar stable and reducing the spike-and-crash pattern that drives cravings.
In practice: steadier energy through the day, fewer afternoon energy crashes, less reactive hunger.
The SELECT trial showed Semaglutide reduced the combined rate of heart attack, stroke and cardiovascular death by 20% in adults with prior cardiovascular disease and overweight.
In practice: a side benefit Semaglutide has that Tirzepatide and Retatrutide do not yet have published outcome data for.
Real numbers from peer-reviewed publications.
All claims above are from peer-reviewed publications. Semaglutide is supplied by GLP+ as a research peptide for in-vitro and laboratory use only. We do not provide medical advice, dosing guidance, or treatment recommendations. For citations and published dosing protocols, see our researcher resources page.
Semaglutide is a single-receptor GLP-1 agonist. It mimics the body's natural GLP-1 hormone, which regulates appetite, gastric emptying, and insulin response. It is the longest-studied of the three weight management GLPs we carry.
Semaglutide activates one receptor (GLP-1). Tirzepatide activates two (GLP-1 and GIP). Retatrutide activates three (GLP-1, GIP and Glucagon). Semaglutide has the longest research history and is often used as a baseline for first-time peptide research.
Our current Bali catalog lists 10mg as the standard size for Semaglutide in both vial and pen. If you need a different size, message us on WhatsApp and we will check availability.
All GLP peptides ship in temperature-controlled packaging with cold-chain protection. Pens and vials arrive intact and ready to refrigerate. Same-day dispatch for orders placed before 5 PM.
Yes. All Semaglutide sold by GLP+ is intended for research purposes only. We do not provide medical advice, dosing guidance, or treatment recommendations.
Semaglutide is the single-receptor baseline. The other two compounds in our catalog activate more receptors.
The dual-action evolution of Semaglutide. Stronger metabolic response in published research, with vial pricing from IDR 3,400,000.
Learn about Tirzepatide →The newest weight management peptide, activating three receptors. Available in 5mg, 10mg and 30mg with vials from IDR 1,800,000.
Learn about Retatrutide →Get same-day responses from our team. Vial or pen, your choice.
Message Us on WhatsApp